骨肿瘤切除后重建中巴氏灭活自体骨是否持久
单中心26年间353例巴氏灭活自体骨重建中278例纳入分析,平均随访113个月。5年、10年、20年移植物生存率分别为73%±5.5%、59%±6.7%、40%±13.6%,105例(38%)因并发症移除。年龄≤15岁、男性、骨盆部位与移除相关;骨关节型和半皮质型生存较好。
要点
- 巴氏灭活自体骨20年生存率仅40%±13.6%,38%因并发症移除。
- 年龄≤15岁、男性、骨盆部位与移植物移除相关。
- 骨关节型和半皮质型移植物生存优于其他重建类型。
核心结论
- 与短期小队列的乐观报告相比,该长期大队列中巴氏灭活自体骨的生存结果令人失望。
- 作者认为在儿童和青少年、骨盆区域及骨假体复合体形式中应谨慎使用巴氏灭活自体骨。
- 作者认为当骨量破坏较小时,小段间置或远端长骨重建可考虑此方法;半皮质切除后长骨重建最佳。
研究设计与样本
- 单中心回顾性研究,1988年至2013年26年间共行1358例肿瘤切除,其中353例采用巴氏灭活自体骨重建。
- 排除75例(21%)后,278例巴氏灭活自体骨纳入分析,平均随访113个月(范围25-295个月)。
- 278例中242例原发骨肉瘤、22例软组织肿瘤侵犯骨、7例转移癌、7例侵袭性良性骨肿瘤。
- 377个连接部位通过连续X线评估愈合,愈合<2年定义为愈合,>2年定义为延迟愈合。
- 重建类型:骨假体复合体149例、间置骨移植71例、半皮质骨移植15例、骨关节型12例、关节融合31例。
主要发现
- 278例巴氏灭活自体骨5年、10年、20年生存率分别为73%±5.5%、59%±6.7%、40%±13.6%。
- 105例(38%)因并发症移除,原因包括感染13%(33例)、不愈合7%(18例)、移植物骨折6%(16例)、移植物吸收5%(14例)、局部复发4%(11例)。
- 单变量生存分析显示年龄≤15岁(p=0.027;HR 1.541)、男性(p=0.004;HR 1.810)、骨盆部位(p=0.05;HR 2.518)与移植物移除相关。
- 骨关节型和半皮质型20年生存率分别为92%(95%CI -15.6%至+8.3%)和80%±20%;间置型46%±15%、融合型28%±22%、骨假体复合体型37%±22%。
- 骨关节型和半皮质型组移植物生存优于其他重建类型(p=0.028;HR 0.499)。
临床怎么用
- 作者认为在儿童和青少年、骨盆区域及骨假体复合体形式中应谨慎使用巴氏灭活自体骨。
- 作者认为当骨量破坏较小时,小段间置或远端长骨重建可考虑此方法。
- 作者认为该手术最佳适应证为长骨半皮质切除术后重建。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pasteurized autograft is regarded as a biologic reconstructive option for managing bone defects after tumor resection; however, reports on long-term outcomes from large patient series are scarce. Contrary to previous favorable reports, we have observed many patients with failures, in particular as the duration of followup increased. Because pasteurized autografts are used in many countries as a reconstruction option, we wished to formally evaluate patients who underwent this approach at one specialty center. QUESTIONS/PURPOSES: (1) What is the graft survival and what proportion of patients achieved union when pasteurized autografts were used for bone defects after tumor resection? (2) What are the complications and causes of graft removal? (3) What factors are related to the likelihood of union and graft survival? (4) What is the survival and cause of failure by type of pasteurized autograft reconstruction? METHODS: Over a 26-year period from 1988 to 2013, we performed 1358 tumor resections in our center. Of these, 353 were reconstructed with pasteurized autograft. Other reconstructions included endoprostheses (508 patients), instant arthrodesis using an intramedullary nail and bone cement (286 patients), allografts (97 patients), and resection only (114 patients). During the period in question, we generally used this approach when tumor showed an osteoblastic pattern and less than one-third cortical destruction in osteolytic tumor. We generally avoided this approach when the tumor showed an extensive osteolytic pattern. We excluded 75 (21% [75 of 353]) patients, 21 (6% [21 of 353]) for incomplete clinical data and 54 (15% [54 of 353]) with a followup < 2 years or those lost to followup leaving 278 autografts eligible. The mean followup was 113 months (range, 25-295 months). Of these 278 patients, 242 patients had primary bone sarcomas, 22 patients had soft tissue tumor invading bone, seven patients had metastatic carcinoma, and seven patients had aggressive benign bone tumors. From a chart review, we obtained the age, sex, location, tumor volume, histologic diagnosis, use of chemotherapy, graft length, fixation modality, type of pasteurized bone used, proportion of union, complications, and oncologic outcome of the patients. In total, 377 junctional sites were assessed for union with serial radiographs. We defined junctions showing union < 2 years as union and > 2 years as delayed union. We grouped our patients into type of pasteurized bone use: pasteurized autograft-prosthesis composites (PPCs) were performed in 149, intercalary grafts in 71, hemicortical grafts in 15, osteoarticular in 12, and fusion of a joint in 31 patients. The endpoint of interest included removal of the autograft with implant loosening, infection, fracture of the graft, or any reoperation resulting in removal. Survival of the graft was determined by Kaplan-Meier plot and intergroup differences were determined using log-rank test. RESULTS: Five, 10-, and 20-year survival of 278 autografts was 73% ± 5.5%, 59% ± 6.7%, and 40% ± 13.6%, respectively. Of 278 autografts, 105 (38%) were removed with complications. Cause of removal included infection in 13% (33 patients), nonunion in 7% (18 patients), fracture of graft in 6% (16 patients), resorption of the graft in 5% (14 patients), and local recurrence in 4% (11 patients). Univariate survival analysis revealed that patient age ≤ 15 years (p = 0.027; hazard ratio [HR], 1.541), male sex (p = 0.004; HR, 1.810), and pelvic location (p = 0.05; HR, 2.518) were associated with graft removal. The 20-year survival rate of osteoarticular and hemicortical methods was 92% (95% confidence interval, -15.6% to +8.3%) and 80% ± 20%, respectively. For intercalary and fusion, it was 46% ± 15% and 28% ± 22%, respectively, although for PPC, it was 37% ± 22%. Log-rank survival analysis showed the osteoarticular and hemicortical groups had better graft survival compared with other types of reconstruction (p = 0.028; HR, 0.499). The most prevalent cause of graft removal in three major types of reconstruction was as follows: (1) PPC type was infection (30% [17 of 56]); (2) intercalary graft was infection, nonunion, and local recurrence in even proportions of 29% (86% [24 of 28]); and (3) fusion was infection (35% [six of 17]). Two hundred ten (56%) of 377 junctional sites showed union within 2 years (average, 14 months), 51 (13%) junctions showed delayed union after 2 years (average, 40 months), and the remaining 116 (31%) junctions showed nonunion. Diaphyseal junction (p = 0.029) and male sex (p = 0.004) showed a higher proportion of nonunion by univariate analysis. CONCLUSIONS: Compared with the favorable short-term and small cohort reports, survival of pasteurized autograft in this long-term large cohort was disappointing. We believe that pasteurized autograft should be used with caution in children and adolescents, in the pelvic region, and in PPC form. When bone stock destruction is minimal, it is worth considering this approach for small intercalary or distal long bone reconstruction. We believe this procedure is best indicated after hemicortical resection of long bone. LEVEL OF EVIDENCE: Level III, therapeutic study.
引用
- Lee SY, Jeon DG, Cho WH, et al. Are Pasteurized Autografts Durable for Reconstructions After Bone Tumor Resections? Clin Orthop Relat Res. 2018. PMID: 30794210. doi:10.1007/s11999.0000000000000100
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。